Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease
about
Noninvasive predictors of fibrosis in NASH with and without cirrhosis, just as good as histology (and hepatic venous pressure gradient?).Characterization of transcriptional modules related to fibrosing-NAFLD progression.Future therapy of portal hypertension in liver cirrhosis - a guess.Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C VirusEvaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis CSimple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseaseHepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.Mouse models of metabolic liver injury.Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health.Splenosystemic shunts in cats: a retrospective of 33 cases (2004-2011).A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.Pilose antler peptide attenuates high-fat-diet-induced liver injury.Helicobacter pylori on portal hypertension-related hepatic encephalopathy.Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease.
P2860
Q30316067-8F5A902E-E1B5-498A-8178-03DCD01700BCQ33881352-E33BEA11-A76E-4D14-8AE6-4780DBB86D70Q34446521-EA021AB8-C0BB-4210-A773-A56FF584FEEAQ35893923-96137D28-8340-485F-9FF7-CD733DC72243Q37286603-87D7DE52-A37F-4ED8-AF06-2942DEC7CA09Q37535574-0755824C-3F9C-4A26-A6FF-61934913F469Q37596730-3F4FBC2E-4993-4381-AEE9-1CB6D472FA97Q37696171-875E10CC-9E1D-4687-8CF9-429544A93AD8Q38402052-5229A8A6-69CD-406A-BAAE-0D02625FDE0BQ38966889-9F876E18-A92B-425A-BD50-6D1C4E28E62BQ42617460-F4E17D8F-AB8A-45C0-9587-3F78612210DCQ42707414-B126D475-E7DE-4F42-B35C-96DFA2070948Q47424206-7E7863E5-3307-439D-914D-57C1A139EBBAQ52905495-28FFD130-FA57-4876-A9A2-8F847BD1C980Q55017777-14E7D730-F550-423F-B8FD-F5FC4916EA5B
P2860
Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@ast
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@en
type
label
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@ast
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@en
prefLabel
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@ast
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@en
P2093
P2860
P1476
Prevalence and indicators of p ...... nalcoholic fatty liver disease
@en
P2093
Ayako Suzuki
Flavia D Mendes
Keith D Lindor
Paul Angulo
Schuyler O Sanderson
P2860
P304
1028-33.e2
P356
10.1016/J.CGH.2012.05.008
P407
P577
2012-05-18T00:00:00Z